Clinical trial
Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of…
NCT00149383 · Mahidol University, Other · Completed
Key facts
| NCT number | NCT00149383 |
|---|---|
| Title | Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria |
| Official title | A Randomized, Double-blind, Placebo-controlled Trial of Rosiglitazone as Adjunctive Therapy for P.Falciparum Infection |
| Lead sponsor | Mahidol University, Other |
| Collaborators | McLaughlin-Rotman Center for Global Health, University of Toronto |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Falciparum Malaria |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Placebo |
| Enrollment | 140 |
| Start date | Dec 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 13, 2015 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: